Key Highlights

  • AVVH slid about 6.3% at last closing to near $0.0015, a Market Value of roughly $1.5 million.
  • The company filed Form 15 notices to terminate its SEC registration around 2008 to 2009 and has not resumed periodic reporting.
  • It historically marketed a skin-care line under the 'Neuroskin' name from a Nevada incorporation.
  • No verified, market-moving regulatory or commercial catalyst has been identified behind the recent price move.

Some tickers on the U.S. over-the-counter market are less "stocks" in the conventional sense than dormant corporate shells trading in fractions of a penny. AVVAA World Health Care Products, Inc. (OTC:AVVH) sits firmly in that category. Quoted around $0.0015 with a market value near $1.5 million, the company is a nano-cap skin-care and wellness venture whose shares swing on tiny absolute price changes. A reported slide of about 6.3% translates to a fraction of one-hundredth of a cent.

Company and Latest Development

AVVAA World Health Care Products describes itself as a developer and marketer of health and skin-care products, historically associated with a "Neuroskin" line, and was incorporated in Nevada with earlier operations tied to Canada. It is a very small operation, reportedly with only a handful of employees. The most recent identifiable development is a company Shareholder update circulated around December 2025 that reviewed 2025 activities and outlined a roadmap for 2026; the Business has also been associated with a 2022 combination involving GoldQuest Capital. None of these represent a verified, market-moving regulatory or commercial catalyst.

What Is Driving Attention Around AVVH?

There is no clearly identifiable public catalyst behind the recent move. As a sub-penny security, AVVH can register large percentage swings on negligible dollar changes and minimal trading volume, so a roughly 6.3% slide reflects the mechanics of a thinly traded nano-cap rather than a confirmed news event. Importantly, AVVAA is not a current SEC reporting company: EDGAR records show it filed periodic reports in the mid-2000s but then filed Form 15 notices to terminate its registration around 2008 to 2009. That means limited, non-standardized public disclosure today.

Key Numbers and Company Position

Verifiable hard figures are scarce, which is itself the key fact. Market-data providers place the share price near $0.0015 and the market Capitalization around $1.5 million, with only a few employees listed. Because the company deregistered from SEC reporting more than a decade ago, there are no recent audited quarterly or annual financials on EDGAR to anchor revenue, cash or earnings. Any operating metrics would come from company-issued disclosures rather than filed, audited SEC reports, and should be treated with caution.

What Could Come Next?

For a company of this profile, meaningful catalysts would be basic and structural: resumption of regular financial disclosure, verifiable product revenue, a financing, or a genuine corporate transaction. Anyone following AVVH would look for concrete, independently verifiable updates, filed financials, a signed commercial agreement, or a return to SEC reporting, rather than promotional shareholder letters. Absent those, the shares are likely to keep trading on sentiment and speculation rather than fundamentals.

Risks to Watch

The risks here are pronounced. Sub-penny OTC securities are prone to wide bid-ask spreads, extreme illiquidity, and outsized percentage volatility. The lack of current SEC reporting means investors have limited audited information and reduced regulatory oversight. Nano-cap shells can face dilution, going-concern uncertainty, and the real possibility that shares hold little or no realizable value. Such stocks are also frequent vehicles for promotional activity, warranting heightened skepticism from any prospective investor.

A Dormant Shell, Not an Active Growth Story

AVVAA World Health Care Products is best understood as a dormant-to-marginal, sub-penny OTC nano-cap rather than an actively covered growth story. Investors intrigued by AVVH may want to Demand verifiable, filed disclosure before treating any move as meaningful, while weighing the profound Liquidity and information risks involved.